Bellerophon Therapeutics Announces Closing of $43.7 Million Public Offering of Common Stock and Concurrent Registered Direct Offering and Full Exercise of Option to Purchase Additional Shares

by NASDAQ Market News May 22, 2020

NASDAQ Market News
Click here to email author

Infectious Disease Diagnostics Market to reach US$ 1,841.2 Million globally by 2027 – Coherent Market Insights

Generex Subsidiary NGIO Advances COVID-19 Vaccine Program with the Manufacturing of Patent-Pending Ii-Key-SARS-CoV-2 Peptides

Ads